Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
remus pharmaceuticals l stock

REMUS PHARMACEUTICALS L Share Price

2340.1 -16.34 (-0.69%)
Nov 21 2024 03:05 PM Pharmaceuticals NSE: REMUS

REMUS PHARMACEUTICALS L Share Price Update

As of the latest trading session, REMUS PHARMACEUTICALS L share price is currently at 2340.1, which is down by -16.34 from its previous closing. Today, the stock has fluctuated between 2290.00 and 2414.00. Over the past year, REMUS PHARMACEUTICALS L has achieved a return of 74.63 %. In the last month alone, the return has been -10.92 %. Read More...

REMUS PHARMACEUTICALS L Performance

Day Range

Low2290.00 High2414.00
2340.10

52 Week Range

Low 1200.00 High 2834.75
2340.10

REMUS PHARMACEUTICALS L Share Price

16154

REMUS

img img img img
No Data Available

Open Price

2414.00

Prev. Close

2356.45

Volume (Shares)

2450.00

Total traded value

57.33

Upper Circuit

2827.70

Lower Circuit

1885.20

Note: The current prices & values are delayed, Login to your account for live updates.

REMUS PHARMACEUTICALS L Fundamentals


(Standalone)

Market Cap (Cr) 344.69
PE Ratio (TTM) 81.96
Book Value / Share 139.27
Beta 1.06
ROE 33.24%
EPS (TTM) 28.52
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.00

REMUS PHARMACEUTICALS L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 63.50
Operating Expense 44.67
Net Profit 16.82
Net Profit Margin (%) 26.48
Earnings Per Share (EPS) 29.68
EBITDA 23.74
Effective Tax Rate (%) 25.35
Particulars MAR 2023 (Values in Cr)
Revenue 45.03
Operating Expense 35.19
Net Profit 8.50
Net Profit Margin (%) 18.87
Earnings Per Share (EPS) 83.24
EBITDA 12.12
Effective Tax Rate (%) 25.50
Particulars MAR 2022 (Values in Cr)
Revenue 24.72
Operating Expense 20.83
Net Profit 3.43
Net Profit Margin (%) 13.87
Earnings Per Share (EPS) 34.34
EBITDA 4.85
Effective Tax Rate (%) 25.59
Particulars MAR 2024 (Values in Cr)
Book Value / Share 589.66
ROE % 29.91
ROCE % 32.68
Total Debt to Total Equity 0.13
EBITDA Margin 15.62
Particulars MAR 2024 (Values in Cr)
Book Value / Share 557.11
ROE % 33.24
ROCE % 41.05
Total Debt to Total Equity 0.09
EBITDA Margin 37.39
Particulars MAR 2023 (Values in Cr)
Book Value / Share 176.36
ROE % 66.10
ROCE % 68.21
Total Debt to Total Equity 0.32
EBITDA Margin 26.92
Particulars MAR 2022 (Values in Cr)
Book Value / Share 65.78
ROE % 70.58
ROCE % 92.25
Total Debt to Total Equity 0.05
EBITDA Margin 19.66
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3143.70
ROE % 41.09
ROCE % 48.98
Total Debt to Total Equity 0.12
EBITDA Margin 8.74
Particulars MAR 2020 (Values in Cr)
Book Value / Share 2020.30
ROE % 40.10
ROCE % 45.93
Total Debt to Total Equity 0.18
EBITDA Margin 10.40
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 26.86
Total Assets 257.27
Total Liabilities 257.27
Total Equity 104.33
Share Outstanding 1473000
Price to Book Ratio 12.38
Return on Assets (%) 8.37
Return on Capital (%) 18.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 23.84
Total Assets 98.05
Total Liabilities 98.05
Total Equity 82.06
Share Outstanding 1473000
Price to Book Ratio 12.38
Return on Assets (%) 17.15
Return on Capital (%) 20.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.03
Total Assets 34.66
Total Liabilities 34.66
Total Equity 19.13
Share Outstanding 1085000
Price to Book Ratio 0.00
Return on Assets (%) 24.53
Return on Capital (%) 31.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.14
Total Assets 15.86
Total Liabilities 15.86
Total Equity 6.57
Share Outstanding 1000000
Price to Book Ratio 0.00
Return on Assets (%) 21.65
Return on Capital (%) 50.73
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.83
Total Assets 11.01
Total Liabilities 11.01
Total Equity 3.14
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 9.61
Return on Capital (%) 30.96
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.19
Total Assets 5.30
Total Liabilities 5.30
Total Equity 2.02
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 15.30
Return on Capital (%) 34.11
Particulars MAR 2024 (Values in Cr)
Net Income 31.82
Cash from Operations 10.16
Cash from Investing -8.94
Cash from Financing 24.36
Net change in Cash 19.02
Free Cash Flow 10.80
Particulars MAR 2024 (Values in Cr)
Net Income 22.52
Cash from Operations 8.84
Cash from Investing -20.90
Cash from Financing 39.28
Net change in Cash 20.81
Free Cash Flow 9.48
Particulars MAR 2023 (Values in Cr)
Net Income 11.41
Cash from Operations 8.31
Cash from Investing -15.19
Cash from Financing 11.76
Net change in Cash 1.88
Free Cash Flow 11.04
Particulars MAR 2022 (Values in Cr)
Net Income 4.61
Cash from Operations 6.23
Cash from Investing -4.54
Cash from Financing -0.17
Net change in Cash 0.31
Free Cash Flow 6.30
Particulars MAR 2021 (Values in Cr)
Net Income 1.40
Cash from Operations 0.24
Cash from Investing -0.13
Cash from Financing -0.11
Net change in Cash -0.36
Free Cash Flow 0.31
Particulars MAR 2020 (Values in Cr)
Net Income 1.09
Cash from Operations 1.60
Cash from Investing -0.55
Cash from Financing 0.06
Net change in Cash 0.80
Free Cash Flow 2.16
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 32.10 3.04 428.00 37.54 / 77.70
BLISS GVS PHARMA LTD 120.75 15.11 1.25 1271.52 92.25 / 148.95
CIPLA LTD 1471.35 25.74 4.18 118825.56 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 331.20 115.00 3.35 974.75 145.00 / 354.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 48.57 9.49 428.00 37.54 / 77.70
AMRUTAJAN HEALTH LTD 720.90 43.85 6.99 2084.17 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6497.50 126.19 23.91 16243.75 4050.15 / 8139.85
BLISS GVS PHARMA LTD 120.75 15.72 1.24 1271.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2352.30
  • 26 Days 2503.10
  • 10 Days 2404.00
  • 50 Days 2520.40
  • 12 Days 2430.20
  • 100 Days 2382.40
  • 20 Days 2468.60
  • 200 Days 1659.60
2345.48
PIVOT
First Resistance 2410.97
Second Resistance 2465.48
Third Resistance 2530.97
First Support 2290.97
Second Support 2225.48
Third Support 2170.97
RSI 31.43
MACD -72.91
Commodity Channel Index (CCI) -117.87
ADX 12.26
Williams % R -68.35

Over 1 Month

down

-10.92

Over 3 Months

down

-4.12

Over 6 Months

down

22.66

Over 1 Year

down

74.63

Over 3 Years

down

0.00

Over 5 Years

down

0.00

REMUS PHARMACEUTICALS L Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

REMUS PHARMACEUTICALS L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
26.33
Promoter Holdings
70.66
FII
2.99
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Shah Arpit Deepakkumar Shareholding of Promoter and Promoter Group 1035000.0 17.57
Roma Vindbhai Shah Shareholding of Promoter and Promoter Group 1012400.0 17.18
Swapnil Jatinbhai Shah Shareholding of Promoter and Promoter Group 1000000.0 16.97
Anar Swapnil Shah Shareholding of Promoter and Promoter Group 1000000.0 16.97
Iegfi - Multi Opportunity Public Shareholding 165200.0 2.8
Rekha Gunavanth Kumar Public Shareholding 64000.0 1.09
Hemant Ishwarlal Modi Shareholding of Promoter and Promoter Group 58800.0 1.0
Renosen Pharmaceuticals Private Limited Shareholding of Promoter and Promoter Group 46300.0 0.79
Sonal Hemantbhai Modi Shareholding of Promoter and Promoter Group 4000.0 0.07
Mansi Adarsh Shah Shareholding of Promoter and Promoter Group 4000.0 0.07
Vinodkumar Gandalal Shah Shareholding of Promoter and Promoter Group 3000.0 0.05

REMUS PHARMACEUTICALS L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-10-27 2.0 Interim 2023-10-28 Equity shares 2023-09-15 2.0 Final 2023-09-15 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About REMUS PHARMACEUTICALS L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by REMUS PHARMACEUTICALS L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Remus Pharmaceuticals Ltd?

Answer Field

The share price of Remus Pharmaceuticals Ltd for NSE is ₹ 2340.1 and for BSE is ₹ 0.00.

What is the Market Cap of Remus Pharmaceuticals Ltd?

Answer Field

The market cap of Remus Pharmaceuticals Ltd for NSE is ₹ 3,44.69 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Remus Pharmaceuticals Ltd for NSE is ₹ 2834.75 and ₹ 1200.00 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Remus Pharmaceuticals Ltd share?

Answer Field

You can trade in Remus Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Remus Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 74.63%.

What is the Current Share Price of Remus Pharmaceuticals Ltd?

Answer Field

Remus Pharmaceuticals Ltd share price is for NSE ₹ 2340.1 & for BSE ₹ 0.00 as on Nov 21 2024 03:05 PM.

What is the Market Cap of Remus Pharmaceuticals Ltd Share?

Answer Field

The market cap of Remus Pharmaceuticals Ltd for NSE ₹ 3,44.69 & for BSE ₹ 0.0 as on Nov 21 2024 03:05 PM.

What is the P/E Ratio of Remus Pharmaceuticals Ltd Share?

Answer Field

As on Nov 21 2024 03:05 PM the price-to-earnings (PE) ratio for Remus Pharmaceuticals Ltd share is 81.96.

What is the PB ratio of Remus Pharmaceuticals Ltd Share?

Answer Field

As on Nov 21 2024 03:05 PM, the price-to-book (PB) ratio for Remus Pharmaceuticals Ltd share is 139.27.

How to Buy Remus Pharmaceuticals Ltd Share?

Answer Field

You can trade in Remus Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Remus Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Remus Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Remus Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader